PRESBYTERIAN PLANO CENTER DIAG SRVCS — History
CCN 450891 | 3-year financial timeline | COVID resilience: 40/100
🛡️ Public data only — no PHI permitted on this instance.
$82M
Latest Revenue (FY2022)
-0.5%
Revenue CAGR (3yr)
28.4%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $83M | $89M | $82M | -7.5% | -0.5% |
| Operating Expenses | $55M | $60M | $59M | -2.7% | +3.4% |
| Operating Margin | 33.7% | 31.9% | 28.4% | -11.1% | -8.2% |
| Net Income | $28M | $28M | $23M | -17.8% | -8.7% |
| Licensed Beds | 18 | 18 | 18 | +0.0% | +0.0% |
| Total Patient Days | 954 | 803 | 618 | -23.0% | -19.5% |
| Medicare Day % | 22% | 13% | 16% | +24.8% | -16.2% |
| Medicaid Day % | nan% | nan% | nan% | +nan% | +nan% |
COVID Impact & Recovery
Resilience Score: 40/100 — Stressed — slow recovery from COVID
Revenue recovery from FY2020 to FY2022: -1.1% ($83M → $82M)
FY2020 captured the initial COVID shock. Slow recovery suggests structural challenges beyond COVID.
Trend Summary
Revenue▶ Stable
Operating Margin▼ Declining
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
-0.5%
This Hospital
+7.6%
State Avg
Latest Margin
28.4%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $81M | 25.7% |
| FY2024 (proj) | $81M | 23.0% |
| FY2025 (proj) | $81M | 20.4% |